More specifically, p16/INK4 has been found to induce G1 cell‐cycle arrest through the Rb pathway, and both p16 and p14ARF have been identified as modulators of chemo‐ and radiosensitivity in gliomas 23. Here, CDKN2A is linked to central nervous system cancer.